Back | Next |
home / stock / amrn / amrn message board
Subject | By | Source | When |
---|---|---|---|
That would be really relly disappointing to | seve333 | investorshub | 04/19/2024 6:31:27 PM |
They could be saving it for the ER | DAR53 | investorshub | 04/19/2024 6:21:42 PM |
Generic Lovaza is the same thing. | Meowza | investorshub | 04/19/2024 5:19:21 PM |
Well you used the word purify, which of | rosemountbomber | investorshub | 04/19/2024 3:41:38 PM |
Why have the not announced if the buyback | seve333 | investorshub | 04/19/2024 3:27:11 PM |
https://pubmed.ncbi.nlm.nih.gov/17941053/ Discusses Eicosapentaenoic acid aka | OracleCentaur29 | investorshub | 04/19/2024 2:42:34 PM |
🙂👏👏 | Triple88 | investorshub | 04/19/2024 2:27:05 PM |
I'm working on it! | CaptBeer | investorshub | 04/19/2024 2:06:56 PM |
https://twitter.com/GeoWizz /status/1781323015822655759 | CaptBeer | investorshub | 04/19/2024 2:06:18 PM |
Excellent Chart !! | Triple88 | investorshub | 04/19/2024 1:34:59 PM |
Same for $AMRN? | DMC8 | investorshub | 04/19/2024 1:29:17 PM |
FYI: I've updated my REDUCE-IT SG analysis slide | CaptBeer | investorshub | 04/19/2024 1:24:40 PM |
Consider this for $AMRN? | DMC8 | investorshub | 04/19/2024 1:05:05 PM |
but neglect to mention that the other reason | Tatsumaki | investorshub | 04/19/2024 12:50:57 PM |
Amarin has secured a worldwide patent priority claim | ziploc_1 | investorshub | 04/19/2024 12:48:09 PM |
Thanks for catching that and correcting the huge. | rosemountbomber | investorshub | 04/19/2024 11:53:11 AM |
In April 2024, Amarin (NASDAQ: $AMRN) Corporation plc | DMC8 | investorshub | 04/19/2024 8:58:53 AM |
REDUCE-IT Analysis Outlines Benefit of Icosapent Ethyl Across | DMC8 | investorshub | 04/19/2024 8:53:27 AM |
by detaching the EPA from the huge glycerol | Tatsumaki | investorshub | 04/19/2024 6:32:25 AM |
Thx Laurent | Whalatane | investorshub | 04/19/2024 5:04:27 AM |
News, Short Squeeze, Breakout and More Instantly...
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
Amarin Corporation plc Website:
DUBLIN and BRIDGEWATER, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin’s senior management team to discuss its second quarter 2024 results followed ...
-- VASCEPA Approved by the National Medical Products Administration (NMPA) To Reduce the Risk of Cardiovascular Events as an Adjunct to Statin Therapy in Adult Patients with Elevated Triglyceride (TG) Levels (≥150 mg/dL) and Other High-Risk Characteristics as Studied in REDUCE-IT -- ...
-- Board Appoints Aaron Berg as President & CEO -- -- Patrick Holt to Step Down as President & CEO to Pursue Other Opportunities -- DUBLIN and BRIDGEWATER, N.J., June 04, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that the Company’...